2000
DOI: 10.1378/chest.118.6.1616
|View full text |Cite
|
Sign up to set email alerts
|

Use of Intraoperative Hetastarch Priming During Coronary Bypass

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(6 citation statements)
references
References 11 publications
0
5
0
1
Order By: Relevance
“…[30] compared volume replacement with gelatin and LMW-HES 130/0.4; there were no significant differences between the two groups indicating that this LMW-HES 130/0.4 can be safely used in cardiac surgery. All these studies[31‐33] were done in patients scheduled for CABG using the conventional CPB where several other mechanisms related to CPB can be responsible for derangement of coagulation. In our study the deleterious effects of CPB are avoided and it was found that HES with higher molecular weight and degree of substitution cause more impairment of coagulation system.…”
Section: Discussionmentioning
confidence: 99%
“…[30] compared volume replacement with gelatin and LMW-HES 130/0.4; there were no significant differences between the two groups indicating that this LMW-HES 130/0.4 can be safely used in cardiac surgery. All these studies[31‐33] were done in patients scheduled for CABG using the conventional CPB where several other mechanisms related to CPB can be responsible for derangement of coagulation. In our study the deleterious effects of CPB are avoided and it was found that HES with higher molecular weight and degree of substitution cause more impairment of coagulation system.…”
Section: Discussionmentioning
confidence: 99%
“…The most common choice for prime solution have been RL, albumin, HES, and polygeline. Although it was reported that HES, as a prime solution in open heart surgery was more effective regarding its cardiac and systemic effects [5,6] , there are less studies in the literature that monitored cerebral functions. Iriz et al reported that HES is a better prime solution than RL [7] .…”
Section: Resultsmentioning
confidence: 99%
“…The prospective clinical data regarding the use of HES in cardiac surgery is controversial with respect to blood loss and allogeneic blood transfusions. Similar to retrospective studies, many of these studies were performed with Hespan and not HEX 14,17‐20 . Kuitunen and coworkers 18 compared high‐ and low‐molecular‐weight HES (20 mL/kg) with albumin as the main component of the CPB priming solution and observed that while HES solutions were associated with abnormalities in thromboelastographic variables, there was no difference in transfusion requirements among the groups 18 .…”
Section: Discussionmentioning
confidence: 99%